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Abstract
 
Signal transduction through the B cell antigen receptor (BCR) is determined by a balance of
positive and negative regulators. This balance is shifted by aggregation that results from binding
to extracellular ligand. Aggregation of the BCR is necessary for eliciting negative selection or
activation by BCR-expressing B cells. However, ligand-independent signaling through inter-
mediate and mature forms of the BCR has been postulated to regulate B cell development and
peripheral homeostasis. To address the importance of ligand-independent BCR signaling func-
tions and their regulation during B cell development, we have designed a model that allows us
to isolate the basal signaling functions of immunoglobulin (Ig)
 
 
 
/Ig
 
 
 
-containing BCR com-
plexes from those that are dependent upon ligand-mediated aggregation. In vivo, we find that
 
basal signaling is sufficient to facilitate pro-B 
 
→
 
 pre-B cell transition and to generate imma-
ture/mature peripheral B cells. The ability to generate basal signals and to drive developmental
progression were both dependent on plasma membrane association of Ig
 
 
 
/Ig
 
 
 
 complexes and
intact immunoregulatory tyrosine activation motifs (ITAM), thereby establishing a correlation
between these processes. We believe that these studies are the first to directly demonstrate bio-
logically relevant basal signaling through the BCR where the ability to interact with both con-
ventional as well as nonconventional extracellular ligands is eliminated.
Key words: B lymphocytes • pre-B cell receptor • B cell development • B cell antigen 
receptor • signal transduction
 
Introduction
 
All cells respond to environmental stimuli by processing
signals generated as a consequence of plasma membrane
receptors interacting with extracellular ligands. The tradi-
tional model imposes a requirement for extracellular ligand
binding in order to initiate biologically relevant changes in
cellular physiology. Ligand binding results in either con-
formational changes in the receptor which unmask intrin-
sic enzymatic activity or facilitation of interactions be-
tween nonenzymatic motifs in the transmembrane or
cytoplasmic domains and intracellular signal transducing
proteins. Another mechanism by which ligands facilitate
signal initiation is through their ability to aggregate recep-
tor complexes, leading to the sequestration and focusing of
positive regulators of signal transduction and excluding
negative regulators. The antigen receptors on B and T
lymphocytes are classic examples of these latter types of re-
ceptors (1–5). Because of the polymorphic nature of the
ligand binding components which allow these receptors
the potential to interact with a wide diversity of ligands
(antigens), signals are induced through aggregation of non-
polymorphic signaling proteins constitutively associated
with the receptor complex.
 
Both immature and mature stage B cells recognize and
generate signals for B cell responses to polymorphic antigens
through these multi-protein complexes termed the B cell
 
antigen receptor (BCR)
 
*
 
. The BCR is composed of the
ligand-recognizing Ig heavy and light chains in noncovalent
 
association with Ig
 
 
 
 and Ig
 
 
 
 transmembrane proteins. Ig
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and Ig
 
 
 
 are associated as disulfide-linked heterodimers and
mediate the signal transduction function of the BCR. Anti-
gen-mediated aggregation of BCR complexes is required to
trigger and sustain the signaling processes necessary for gen-
erating a signal of sufficient strength and duration to elicit
responses by immature and mature B cells. Aggregation
triggers an intracellular signaling cascade that requires im-
munoregulatory tyrosine activation motifs (ITAMs) present
on the cytoplasmic domains of Ig
 
 
 
 and Ig
 
 
 
 (6, 7). Tyrosine
residues on these motifs become phosphorylated, probably
by Src family tyrosine kinases, and function as platforms for
the recruitment of additional kinases and adaptor proteins,
and subsequent activation of multiple signaling cascades (8).
Recent models have predicted that aggregation of the BCR
results in complexes which are more accessible to receptor
proximal signal transduction (9).
B cell development is an ordered process that allows for
the sequential expression and assembly of the BCR. This
process is associated with the expression of intermediate
forms of the BCR that reflect progress in this ordered pro-
cess and whose expression correlate with distinct check-
points in B cell development (10–17). The earliest stages,
called pro-B cells (18), express pro-BCR complexes that
contain Ig
 
 
 
 in the absence of Ig heavy or light chain ex-
pression. Mice that do not express Ig
 
 
 
 are blocked in de-
velopment at the early pro-B cell stage indicating a poten-
tial role for basal signaling through the pro-BCR (16, 19).
The Ig heavy chain is recombined at the late pro-B cell
stage to allow surface expression of the pre-BCR, which
consists of the heavy chain, 
 
 
 
5, VpreB, Ig
 
 
 
, and Ig
 
 
 
 (12,
13). Deleting components of the pre-BCR, such as the
heavy chain, 
 
 
 
5, or VpreB1 and VpreB2, leads to a pro-B
cell block in development (20–22). This developmental ar-
rest implies that signaling occurs through the pre-BCR and
is further supported by a block at the pro-B cell stage in
knockout mice that lack expression of the BCR-associated
tyrosine kinase Syk (23) or the signaling adaptor Blnk
(SLP65) (24, 25)
 
,
 
 and in humans lacking Ig
 
 
 
, 
 
 
 
5, Blnk, or
the protein tyrosine kinase Btk (26).
These genetic studies demonstrate a requirement for in-
termediate forms of the BCR and their signaling in order
for proper B cell development to proceed. However, the
mechanism by which these signals are generated through
these complexes, in particular the role played by extracellu-
lar ligands in the initiation and maintenance of these sig-
nals, is not established. In one study, the extracellular
ligand-binding domain of IgM was fused to the intracellu-
lar domain of either Ig
 
 
 
 or Ig
 
 
 
, and the chimera was able
to drive B cell development in B cell–deficient mice (27).
The ability of both the pro-BCR and a pre-BCR, in
which the conventional sites for ligand interaction has been
removed, to promote development (28) argues against a re-
quirement for conventional ligand for these Ig
 
 
 
/Ig
 
 
 
 con-
taining complexes to function. Alternatives to conventional
ligand binding, however, include interactions with non-
polymorphic regions of these complexes such as the extra-
cellular regions of the Ig
 
 
 
 and Ig
 
 
 
 proteins themselves. On
the other hand, a role for ligand-independent or basal sig-
naling functions of these complexes has been proposed
(29–31).
Previous studies have suggested a role for basal signals in
the homeostatic survival of peripheral B cells (32). In addi-
tion, basal ligand-independent signaling has been proposed
to play a role in developmental progression and the function
of pre-BCR (33). However, while indirect evidence exists
to imply the independence of these Ig
 
 
 
/Ig
 
 
 
 containing
complexes on extracellular ligand for B cell development
and survival, there currently exists no direct biochemical
evidence for this type of signaling in developing and mature
B cells. For example, while 20–30% of the surface pre-BCR
localizes to glycolipid enriched membrane domains called
rafts (for a review, see reference 34), this localization could
be the result of in vivo ligand encounter before isolation
from the bone marrow. Although the Src family kinase Fyn
has been found to associate with the resting BCR through a
noncovalent association with Ig
 
 
 
, its activity in this context
has not been explored (35, 36). At the functional level,
while previous studies that documented developmental pro-
gression despite an inability of the pre-BCR to interact
with conventional ligands through its polymorphic 
 
 
 
-heavy
chain, they have not eliminated possible interactions
through nonpolymorphic regions of the complex (28). Sim-
ilar studies for the pre-TCR (37) also have not established a
role for similar regions of the CD3 complex to mediate in-
teraction with nonpolymorphic ligands.
Perhaps the best direct biochemical evidence for basal
signaling through the BCR comes from the studies of
Wienands et al. (38). These studies demonstrated BCR-
dependent signaling in the presence of the protein tyrosine
phosphatase inhibitor pervanadate. Presumably the effect of
pervanadate in these studies is to block the activity of pro-
tein tyrosine phosphatases that normally counterbalance
signals generated through the resting BCR (6, 39), thereby
stabilizing signals that are either weak, transient, or both.
Although these studies cannot formally exclude the possi-
bility of homotypic ligands expressed on the B cells them-
selves or of artifactual stimulation, they nevertheless sup-
port the idea that assembled BCR complexes at the plasma
membrane are generating signals in the absence of aggrega-
tion by conventional antigen. However, these studies did
not evaluate the relevance of these signals to B cell function
or physiology.
The current study was designed to test the existence of
ligand-independent signaling functions of BCR complexes
on developing and mature B cells and to evaluate their role
in developmental progression. To do so, we have designed
an experimental model that allows us to isolate ligand-
independent functions of the BCR and its intermediate
forms. Our studies were specifically designed in order to
test the hypothesis that basal signals are generated as a con-
sequence of plasma membrane localization of Ig
 
 
 
 and Ig
 
 
 
.
The described studies establish the ability of plasma mem-
brane localized Ig
 
 
 
/Ig
 
 
 
 complexes to drive early and late B
cell development despite the absence of transmembrane or
extracellular regions with which to interact with extracel-
lular ligands. Furthermore, this model allows us to correlate 
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the ability to generate basal signals with the ability to pro-
mote developmental progression.
 
Materials and Methods
 
Construction of MAHB and Derivatives.
 
Each component of
MAHB was subcloned independently into Bluescript SK (Strat-
agene). Overlapping oligonucleotides for the myristoylation do-
main of murine Lck contained a 5
 
 
 
 EcoRI site with a consensus
Kozak sequence and 3
 
 
 
 BamHI site: MYR-S (sense) 5
 
 
 
-AAT-
TCCACCATGGGCTGTGTCTGCAGCTCAAACCCTGAA-
GATG-3
 
 
 
 and MYR-A (antisense) 5
 
 
 
-GATCCATCTTCAG-
GGTTTGAGCTGCAGACACAGCCCATGGTG-3
 
 
 
. Annealed
oligonucleotides were subcloned into Bluescript SK cut with
EcoRI and BamHI to form SK-Myr. Ig
 
 
 
 (
 
mb-1
 
) and Ig
 
 
 
 (B29)
were cloned by reverse transcription (RT)-PCR using cDNA pre-
pared from the B cell line Bal-17 using the following oligonucle-
otides: Ig
 
 
 
 (sense) 5
 
 
 
-CGCATGGGATCCAGGAAACGGTGG-
CAAAATGAGAAG-3
 
 
 
, Ig
 
 
 
 (antisense) 5
 
 
 
-TGCTCTAGATG-
GCTTTTCCAGCTGGGCATCTCC, Ig
 
 
 
 (sense) 5
 
 
 
-CGGGG-
TACCGACAAGGATGACGGCAAGGCTGGGATG-3
 
 
 
, Ig
 
 
 
(antisense) 5
 
 
 
-CCCAAGCTTCATTCCTGGCCTGGATGCT-
CTCCTAC-3
 
 
 
. Overlapping oligonucleotides for the hemaggluti-
nin (HA) epitope tag contained a 5
 
 
 
 XbaI site and a 3
 
 
 
 KpnI site:
(sense) 5
 
 
 
-GATCCCAGTCTAGATACCCATACGACGTCC-
CAGACTACGCTGGTACCTGA-3
 
 
 
, and (antisense) 5
 
 
 
-TAG-
CTTCAGGTACCAGCGTAGTCTGGGACGTCGTATGGG-
TATCTAGACTGG-3
 
 
 
. Mutations of the ITAM tyrosine residues
were created with overlapping oligonucleotides as follows: Ig
 
 
 
-
ITAMmt (sense) 5
 
 
 
-CTGAACCTTGATGACTGTTCTATGT-
TCGAGGACATCTC-3
 
 
 
, Ig
 
 
 
-ITAMmt (antisense) 5
 
 
 
-ACAG-
TCATCAAGGTTCAGGCCCTCGAAGAGATTTTCA-3
 
 
 
,
Ig
 
 
 
-ITAMmt (sense) 5
 
 
 
-TTGAACATTGACCAGACAGCCA-
CCTTTGAAGACATAG-3
 
 
 
, Ig
 
 
 
-ITAMmt (antisense) 5
 
 
 
-TGT-
CTGGTCAATGTTCAAGCCCTCAAAGGTGTGAT-3
 
 
 
.
 
Immunofluorescence Analysis of MAHB Expression.
 
HeLa cells
were grown on coverslips and fixed in 2% formaldehyde, 0.1%
glutaraldehyde, in PBS for 20 min, followed by washing three
times in PBS for 5 min. The cells were incubated with anti-HA-
biotin (Boehringer) diluted to 0.2 
 
 
 
g/
 
 
 
l in incubation buffer
(PBS containing 0.2% saponin, 0.1% BSA, and 0.02% sodium
azide) for 1 h in a humid chamber. The coverslips were washed
three times and then incubated with streptavidin-FITC (BD
PharMingen; 1:100) in incubation buffer for 1 h. After washing
three times, the coverslips were mounted onto slides using Fluor-
omount-G (Southern Biotechnology Associates, Inc.) and visual-
ized by immunofluorescence microscopy.
 
Electron Microscopy.
 
Electron microscopy was performed by
the biomedical imaging core facility at the University of Pennsyl-
vania. Cultured J558L-MAHB19A4 cells were washed in PBS
and fixed in 4% paraformaldehyde plus 0.2% glutaraldehyde in
0.1 M sodium cacodylate buffer for 4 h. After the dehydration in
graded alcohol they were infiltrated and embedded in LR White
resin and cured at 58
 
 
 
C for 18 h. 90-nm thick sections were cut
using a Diatome Diamond Knife and a Leica ultracut S micro-
tome. Sections were picked up on 200 mesh nickel grids and
nonspecific binding was blocked with 1% ovalbumin plus 0.2%
cold water fish skin gelatin in PBS at room temperature (RT) for
60 min and then transferred to anti-HA (Boehringer 12CA5)
overnight at 4
 
 
 
C. The next day the grids were washed in Tris
buffer and incubated with 10 nm labeled anti–mouse Ig for 1 h at
RT. After washing and staining with 2% Uranyl acetate for 3 min
 
the sample was observed in JEOL JEM 1010 transmission elec-
tron microscope and images captured using the Hamamatsu
CCD camera and AMT 12-HR imaging software.
 
J558L Infection and Derivation of Cell Lines.
 
The murine my-
eloma J558L and J558L-
 
 
 
M3 cell lines were previously modified
to express CD19 and CD45 (40, 41), and all J558L cell lines used
in this study were derived from these variants. The J558L cell
lines and clones were grown in Iscove’s Modified Dulbecco’s
Medium with 25 mM HEPES, 5% heat-inactivated fetal bovine
serum, 2 mM L-glutamine, nonessential amino acids, 50 
 
 
 
M
 
 
 
-mercaptoethanol, and 100 U/ml Penicillin-streptomycin, at
37
 
 
 
C and 5% CO
 
2
 
. For retroviral infection of J558L cells, con-
structs subcloned into the MIGR1 vector were transfected via
CaPO4 into the Bosc 23 packaging cell line as described (42, 43).
2 
 
  
 
10
 
6 
 
J558L cells were spin infected by resuspending in 2 ml
of 1:1 growth medium to retroviral supernatant containing
polybrene at a final concentration of 4 
 
 
 
g/ml and centrifuged at
1,000 
 
g
 
 for 1.5 h at 25
 
 
 
C. After infection, the cells were resus-
pended in medium. Retrovirally infected J558L cell lines were
analyzed for CD45 expression using biotinylated anti-CD45
(I3/2.5) followed by streptavidin-PE (BD PharMingen). Cells
(10
 
6
 
) were washed twice and resuspended in 200 
 
 
 
l of culture
medium containing 0.5% FBS instead of 5% FBS. Cells were
sorted based upon GFP and CD45 expression directly into 96-
well plates using a Becton Dickinson FACStar
 
PLUS™
 
.
 
Sucrose Density Gradient Centrifugation.
 
The J558L
 
 
 
M3 cell
line was infected with MAHB to create the cell line 
 
 
 
M3-
MAHB3. These cells were lysed on ice in a 1% Triton X-100 ly-
sis buffer and subjected to sucrose gradient separation as described
(44).
 
Analysis of Protein Phosphotyrosine Substrates in Pervanadate Treated
J558L-derived Cell Lines.
 
Pervanadate/ H
 
2
 
O
 
2
 
 was made by
mixing 1 ml 20 mM orthovanadate with 330 
 
 
 
l 30% H
 
2
 
O
 
2
 
 at
25
 
 C for 5 min, yielding a solution of 6 mM pervanadate plus
remaining H2O2. This stock was diluted to 100  M pervanadate
in RPMI to make a 2  solution. Cells (5   106 cells) from
J558L subclones were washed with RPMI and resuspended in
0.5 ml RPMI. Prewarmed cells (0.5 ml) and pervanadate (0.5
ml) were mixed together and incubated for 2 min at 37 C. Cells
were pelleted by spinning 5 s in a microfuge, and then resus-
pended in 100  l RIPA lysis buffer (PBS containing 1% N-P40,
0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, 1 mM
orthovanadate, and 1.5  g/ml each of pepstatin A, leupeptin,
chymostatin, and antipain) for 15 min at 4 C. Lysates were clar-
ified by centrifugation at 12,000 rpm in a microfuge for 10 min.
Protein concentration was determined and 100  g of each sam-
ple were loaded onto an SDS-PAGE 6–12% polyacrylamide
gradient gel, followed by transfer to nitrocellulose membranes.
After blocking with 10% FBS in TBST (10 mM Tris pH 7.5,
0.9% NaCl, 0.1% Tween 20), Western blot analysis was per-
formed using anti-phosphotyrosine antibody (4G10, UBI, di-
luted 1:5,000). Phosphoproteins were visualized using peroxi-
dase-labeled horse anti–mouse IgG (Vector Laboratories) as a
secondary antibody followed by enhanced chemiluminescence
(ECL).
HA and Fgr protein levels on stripped and reprobed mem-
branes were accomplished in a similar manner except that 3%
milk in TBST was used for blocking. Mouse anti-HA (16B12,
diluted 1:2,000) or rabbit anti-Fgr antibodies were used as pri-
mary reagents with peroxidase-conjugated horse anti–mouse
IgG (Vector Laboratories) or donkey anti–rabbit IgG (Amer-
sham Pharmacia Biotech), respectively, used as secondary anti-
bodies.1586 BCR Ligand-independent Signals for B Cell Development
Retroviral Infection of Progenitor-enriched Cultures and Bone Marrow
Transfer. Infection of bone marrow cells from female Rag2 / 
BALB/c mice (The Jackson Laboratory) with green fluorescent
protein (GFP)-normalized retroviral supernatants and transplanta-
tion of these cells into lethally irradiated (950 rad) 6–8-wk-old fe-
male syngeneic recipients was performed as described (42). Spin-
oculations were performed in medium containing IL-3 (6 ng/ml;
R&D Systems), IL-6 (10 ng/ml; R&D Systems), stem cell factor
(100 ng/ml; R&D Systems), and 5% WEHI-conditioned super-
natant as described. On day 3 after bone marrow harvest, 5   105
cells were injected into syngeneic 6–8-wk-old female mice that
had been lethally irradiated (950 rad).
Flow Cytometry Analysis of Bone Marrow and Splenic B Cells.
Mouse bone marrow or splenocytes were erythrocyte-depleted
using Gey’s solution. Cells were analyzed for expression of B cell
developmental markers using CD19-biotin(1D3) and CD43-PE
(S7) (BD PharMingen) followed with streptavidin-allophycocya-
nin (APC; BD PharMingen), or B220-APC (RA3–6B2), IA/IE-
PE (2G9), and CD23-biotin (B3B4) (BD PharMingen) followed
with streptavidin-Red670 (GIBCO BRL). Samples stained with
CD19 and CD43 were treated with 10  g/ml propidium iodide
immediately before analysis to allow for dead cell exclusion.
Results
MAHB Is a Model for Aggregation-independent, Basal Sig-
naling Functions of BCR Complexes. The chimeric protein
MAHB (Fig. 1 A) was designed to model potential
ligand-independent functions of the BCR complex and its
intermediate forms that are expressed during B cell devel-
opment (13, 45–47). MAHB consists of the entire cytoplas-
Figure 1. Recombinant pro-
tein MAHB targets Ig  and Ig 
cytoplasmic domains to the
plasma membrane. (A) MAHB
contains an NH2-terminal myris-
toylation/palmitoylation domain
from Lck (M) cloned upstream of
the cytoplasmic domains of Ig 
(A) and Ig  (B), and separated by
a 10 aa spacer containing a HA
peptide tag (H). AHB lacks the
NH2-terminal myristoylation/
palmitoylation site. (B) Expres-
sion and subcellular distribution of MAHB. (Left) HeLa cells were transiently transfected with the expression vector pSV2Zeo containing MAHB (top) or
AHB (bottom). Cells were fixed and stained with biotinylated 12CA5 (anti-HA) followed with SA-FITC, which detects MAHB as green. (Right) Pro-B
cells from RAG2 /  mice were grown in vitro with IL-7 and were infected with the retrovirus MIGR1.str, which coexpresses GFP (shown in green) and
either MAHB (top) or AHB (bottom). Cells were fixed and stained with 12CA5-rhodamine, which detects MAHB by red fluorescence. (C) Electron mi-
croscopy of the MAHB myeloma clone J558L-MAHB19A4. Cells were fixed in resin, and sections were stained with a primary antibody reacting against
HA and a secondary antibody containing gold particles (18 nm). MAHB is detected as black spots. (D) Sucrose gradient fractionation. The BCR-positive
J558L- M3 cell line was infected with MAHB and the resting cell line was lysed on ice and subjected to sucrose gradient fractionation as described in Ma-
terials and Methods and reference 44). Fractions were removed, equal volumes were loaded onto a polyacrylamide gel, and blots were subjected to Western
blot analysis using antibodies to IgM (top) or MAHB (bottom). Fractions 1–3 contain buoyant raft fractions, and fractions 8–11 contain soluble fractions.1587 Bannish et al.
mic regions of the murine Ig  (CD79a; amino acid [aa]
160–222) and murine Ig  (CD79b; aa181–238) signaling
components of the BCR. Each of these regions contain not
only the ITAM motif for which there is a known require-
ment in BCR signal transduction and B cell development
(48, 49), but also additional regions that are less well de-
fined (50, 51). These portions of MAHB are separated by a
10 aa spacer containing an epitope tag from the influenza
virus protein HA.
To isolate ligand and aggregation-independent processes
from those mediated by extracellular ligand-mediated ag-
gregation, we used the Lck myristoylation/palmitoylation
sequence (murine Lck aa1–10) as a targeting motif. By so
doing, MAHB could be targeted to the inner leaflet of the
plasma membrane without transmembrane and extracellu-
lar sequences that could mediate potential ligand-induced
effects. In so doing, this design allows the modeling of  / 
plasma membrane complexes in a manner that obviates in-
teractions with extracellular conventional as well as non-
conventional ligands. The Lck targeting sequence was spe-
cifically chosen for this model because previous studies had
demonstrated noncovalent interactions of murine Lck with
the BCR in “resting” primary murine B cells and B cell
lines (52, 53). Therefore, we reasoned that this targeting
strategy would direct MAHB to regions of the plasma
membrane that are normally occupied by the BCR when
in its unligated and nonaggregated state.
Fig. 1 B demonstrates the ability to target MAHB to the
plasma membrane in Hela cells (Fig. 1 B, left panel) and
primary murine pro-B cells (Fig. 1 B, right panel). The lat-
ter were derived from IL-7 maintained Hardy Fraction C
and C’ (late pro-B) (18) murine B cells that had been in-
fected with the MIGR1 retrovirus expressing MAHB. In
both cases, localization was dependent upon the targeting
motif since its removal in the AHB truncation results in cy-
toplasmic localization of the chimeric protein.
The relatively uniform distribution of MAHB in the
plasma membrane of the HeLa and pro-B cells suggests
that MAHB does not exist in a constitutively aggregated
state nor is it selectively targeted to specialized regions of
the plasma membrane. The former conclusion was further
substantiated by transmission election microscopic analysis
(Fig. 1 C). A representative section of J558L B cells ex-
pressing MAHB shows that the protein is dispersed at the
plasma membrane. Furthermore, sucrose density gradients
of Triton X-100 solubilized membranes from J558L B
cells that coexpressed MAHB and conventional BCR
(IgM form) determined that MAHB and IgM reside
within the same fractions (Fig. 1 D). In our hands, con-
ventional BCR (and also MAHB) is resident in both the
buoyant raft fractions (1–4) and nonbuoyant fractions
even in the absence of ligand-induced aggregation. Nota-
bly, aggregation results in a redistribution and increase in
the number of receptor complexes in the buoyant frac-
tions as has been shown by others (44). These latter ob-
servations suggest that MAHB and the conventional BCR
localize to similar plasma membrane regions in resting B
cells.
Although our localization data in Fig. 1 suggested that
MAHB did not self aggregate, we attempted to rule this
out using a more functional readout. Fig. 2, A and B, are
phosphotyrosine immunoblots comparing conventional
BCR-expressing (J558L- m3) and MAHB-expressing
(MAHB19A4) variants of the J558L B cell line. The paren-
tal J558L B cells lack surface expression of the BCR as well
as CD45 and CD19. The variants used in our studies have
been engineered to express the BCR in the case of the
 m3 variant, and all lines have been transfected so that they
express both B220 and CD19 (41, 54). MAHB was intro-
duced into the BCR nonexpressing variant through retro-
viral infection, followed by sorting and limiting dilution
cloning, so as to generate MAHB-expressing lines.
In Fig. 2 A one can observe that a significant signal is
only detectable when the conventional BCR is aggregated
with anti-IgM antibodies. The blots were stripped and re-
probed with an antibody to the Src family kinase Fgr for use
as a protein loading control. If MAHB was generating sig-
nals as a consequence of forming spontaneous stable aggre-
gates or localizing to regions of the plasma membrane that
bypasses a need for ligand, one would predict that it should
resemble anti-IgM stimulated J558L- m3 in the absence
of pervanadate. The lower band present in the MAHB-
expressing B cells and absent in the J558L- m3 is the phos-
phorylated MAHB protein (asterisk). A similar but faint
band migrating slightly higher in the anti-IgM stimulated
 M3 lane (Fig. 2 A) is Ig  as determined by Western blot-
ting (unpublished data). In contrast to these results, both
MAHB and the conventional BCR expressing B cells dem-
onstrate a detectable signal after incubation with the pro-
tein tyrosine phosphatase pervanadate (Fig. 2 B). Impor-
tantly, in the absence of MAHB or the conventional BCR,
J558L B cells and B cells infected with an empty MIGR
retrovirus failed to demonstrate the extensive pattern of in-
ducible protein phosphotyrosine substrates. The depen-
dence on MAHB or the conventional BCR for generating
pervanadate-induced signals supports the notion that these
structures are generating basal signals which are stabilized
by tyrosine phosphatase inhibition (38). Furthermore, the
similar pattern of phosphotyrosine substrates in the pervan-
adate-treated J558L- m3 and MAHB19A4 argues that the
chimeric protein accurately models these stabilized signals,
both qualitatively as well as quantitatively.
This conclusion is further supported by the dose–
response data shown in Fig. 2 C. Here we have employed
lower doses of pervanadate in order to detect potential dif-
ferences in the quantitative levels of signal between
MAHB and the conventional BCR that could be obscured
by the higher doses. Our ability to first discern a pervana-
date-associated signal occurs at 5  M pervanadate. At this
point, the BCR signal is equal to or greater than that de-
pendent on MAHB expression. Although these assays are
variable from one experiment to another, the experiment
shown in Fig. 2 C is typical in failing to demonstrate a
marked, reproducible, quantitative difference in the level
of pervanadate-stabilized signal when comparing conven-
tional BCR with MAHB.1588 BCR Ligand-independent Signals for B Cell Development
The apparent lack of evidence for self-aggregation or
membrane compartmentalization argues that MAHB is an
appropriate model of the BCR in its unligated state. The
similarity of the pervanadate stabilized signals when com-
paring MAHB to the conventional BCR supports the
conclusion that MAHB accurately models what little pub-
lished biochemistry exists for basal signaling through the
conventional BCR (38). Using this model, we wished to
now address the hypothesis that targeting of Ig  and Ig 
to the plasma membrane is sufficient to generate basal sig-
nals and that these signals are biologically relevant to de-
veloping B cells.
MAHB Can Mediate Positive Selection of B Cells through the
Pro-B → Pre-B Checkpoint. The above studies provide
biochemical evidence to support the conclusion that
MAHB provides an appropriate experimental model to iso-
late and test the biological relevance of aggregation-inde-
pendent functions of the BCR. To test whether these sig-
nals are sufficient to mediate the positive selection normally
generated through the pre-BCR, we retrovirally infected
MAHB into hematopoietic progenitors from  MT mice.
B cell development in these mice is arrested at the pro-B
→ pre-B transition due to the inability to assemble a pre-
BCR at the plasma membrane (20). This arrest can be
assessed by the inability of these mice to generate
CD22posCD43neg B cells in the bone marrow and a com-
plete absence of IgMpos B cells in the periphery (20, 21).
Stem cell progenitors from  MT mice were infected
with empty (MIGR) and MAHB-expressing (MAHB) ret-
rovirus and transferred into lethally irradiated  MT recipi-
ent mice. The GFP marker afforded us the ability to distin-
guish infected from uninfected cells. In so doing, direct
comparisons between wild-type  MT and MAHB-
expressing  MT cells (or MIGR controls) could be ac-
complished in the same recipient mouse. The top panels
are analyses of unmanipulated C57Bl/6 and  MT bone
marrow and spleen (Fig. 3, A and B, respectively). As ex-
pected, the  MT mice lack the B220pos, CD22pos popula-
tion in the bone marrow that is comprised of pre-B,
immature, and recirculating mature B cell subsets present
in the normal C57Bl/6 mice.  MT mice exhibit a com-
plete lack of splenic CD19pos B cells (top panel, Fig. 3 B).
Compare this to C57Bl/6 spleen which has a significant
population of CD19pos splenocytes, the vast majority of
which are CD43neg indicating progression past the proB
cell stage (18). Fig. 3, C and D, compares CD22 and
CD43 expression on B cells generated from  MT progen-
itors expressing MAHB with those expressing empty virus
Figure 2. Comparison of
ligand-induced and basal signal-
ing through MAHB and the
conventional BCR. (A) The in-
dicated derivatives of the J558L
B cell line were either untreated
(left) or treated with anti-IgM
(10  g/ml) for 5 min (right), and
proteins from whole cell lysates
were separated by SDS-PAGE,
transferred to nitrocellulose
membranes, and detected by
Western blotting using the an-
tiphosphotyrosine antibody 4G10.
The blot was stripped and re-
probed with an antibody to Fgr
for use as a protein loading con-
trol. (B) The same conditions as
in panel A except that the cell
lines were treated with pervana-
date (50  M) instead of anti-IgM.
The (*) indicates the position of
the MAHB protein. (C) Titra-
tion of pervanadate. The indi-
cated concentrations of pervana-
date were included in the media
of J558L,  M3, MIGR12B3,
and MAHB19A4 cell lines.
Then, 166,000 cell equivalents
per lane were subjected to West-
ern analysis using the antiphos-
photyrosine antibody 4G10 as in
panel A. At 50  M pervanadate,
the intensities of bands in the
BCRpos   M3 and the
MAHB19A4 cell lines were more
intense than the negative control
cell lines J558L and MIGR12B3.1589 Bannish et al.
(MIGR) or uninfected B cells (GFPneg). Uninfected GFPneg
B cells present in both experimental groups fail to down-
regulate CD43 or up-regulate CD22 surface expression in
the bone marrow and spleen, respectively (see left-most
panels of Fig. 3, C and D). This indicates that in the ab-
sence of MAHB, B cell progenitors maintain the develop-
mental arrest characteristic of the  MT mouse. In contrast,
GFPpos B cells from the MAHB mouse express MAHB and
resemble the wild-type mouse in that they express CD22
in the bone marrow, are present in the spleen, and lack
CD43 expression (see top right panels of Fig. 3, C and D).
The small fraction of GFPnegCD19posCD43pos B cells in the
spleens of MAHB mice could be the result of a low pro-
portion of stem cells homing to the spleen during the
adoptive transfer (55) and subsequent B cell development
within the spleen. This notion is further supported by sim-
ilar findings in MIGR mice (Fig. 3, C and D, bottom right
panels) and in mock-infected adoptive transfer experiments
(unpublished data).
These results clearly demonstrate that MAHB can over-
come the arrest in B cell development that is associated
with the  MT mutation. More importantly, they argue for
biological relevance for the aggregation-independent sig-
nals modeled by MAHB. These results imply that basal sig-
nals generated as a consequence of plasma membrane tar-
geting of Ig /Ig  complexes have a biological function
that is linked to the process of positive selection during B
lymphopoiesis.
MAHB-mediated Signals Drive Progression to the Peripheral
Transitional Immature/Mature B Compartments of B Cell De-
velopment. To determine whether the MAHB-expressing
cells continue through development or alternatively arrest
at the pre-B stage, we evaluated expression of two markers
present in later stages of B cell development, MHC class II
and CD23. MHC class II is not expressed on pro-B cells
and is only expressed weakly or not at all at the pre-B
stage. However, it is expressed strongly on a subset of the
more advanced immature B cells in the bone marrow (56)
and on mature B cells. CD23 is expressed only on periph-
eral transitional immature and mature B cells (57, 58).
Splenic cells from MAHB or MIGR mice were stained
with B220, CD23, and MHC class II antibodies, gated on
a forward/side scatter lymphocyte gate, and divided into
GFPneg (Fig. 4, left) or GFPpos (Fig. 4, right) fractions. Sim-
ilar to the previous analyses, the GFPneg fraction of cells
that do not express MAHB likewise contain few splenic B
Figure 3. Bone marrow B cell development in MAHB-expressing  MT progenitors. Bone marrow from wild-type and  MT mice were analyzed by
flow cytometry for surface expression of CD22 and CD43, along with the pan B cell markers B220 or CD19, in order to identify proB stage cells
(CD22neg, CD43pos) from those B cells which have traversed the pro-B → pre-B checkpoint (CD22pos, CD43neg). Dead cells were excluded by propid-
ium iodide exclusion in order to focus analysis on all live cells in the population. (A) B cell expression in the bone marrow. Wild-type mice (left panel)
contain B cells (B220pos) at the pro-B stage (CD22neg) and at later stages (CD22neg). In contrast, B cells in  MT mice (right panel) are all at the pro-B
stage. (B) B cell expression in the spleen. Wild-type mice (left panel) contain B cells (CD19pos) in the spleen, and they have progressed past the pro-B
stage because they lack CD43. The  MT mice (right panel) completely lack B cells in the spleen (no CD19pos cells). (C) Bone marrow of lethally irradi-
ated  MT mice adoptively transferred with retrovirus infected  MT bone marrow hematopoietic progenitors expressing either MAHB (top) or the
empty virus vector MIGR (bottom panels). Analyses were performed 4 wk after adoptive transfer. GFPpos cells (right) are those derived from progenitors
successfully infected with the indicated retrovirus; GFPneg cells (left) represent noninfected cells for comparison. The boxed region represents B cells that
have progressed past the pro-B stage. Only cells from GFPpos,  MT mice contain a significant fraction of these developed B cells (boxed region of top
right panel). (D) B cell development in splenic B cells from MAHB-expressing  MT mice. Spleens from adoptively transferred  MT mice were ana-
lyzed for expression of the B cell marker CD19 and the pro-B marker CD43, and results are shown as in C. Only GFPpos cells from MAHB mice contain
a significant fraction of B cells (CD19pos), and they have developed past the pro-B stage (boxed region of top right panel).1590 BCR Ligand-independent Signals for B Cell Development
cells and lack CD23 and MHC class II on their surface.
The MIGR mouse also shared this phenotype, as well as a
control   MT spleen, which lacks B cells (see Fig. 3).
However, most splenic B cells from the GFPpos MAHB
mouse expressed both MHC class II and CD23 (Fig. 4, A
and B, top right quadrants of top right panels) and these
cells coexpressed both markers (unpublished data). This
was consistent with B cells seen in a wild-type mouse
spleen. Therefore, we conclude that signals generated by
MAHB are sufficient for transition through both early and
late checkpoints of B cell development.
Low Levels of MAHB Expression Mediate Positive Selec-
tion. The pre-BCR is expressed at low levels on the sur-
face of late pro-B and pre-B cells and is almost undetect-
able by surface staining and flow analysis. One potential
caveat to our studies is that retroviral infection leads to
overexpression of MAHB relative to physiological levels of
the surface pre-BCR. If the difference in signaling between
an activated versus resting pre-BCR or BCR is purely
quantitative, then high levels of MAHB may imitate an ag-
gregated receptor and aggregation of the pre-BCR might
be required for developmental progression. One argument
against this caveat is our observation that basal signals medi-
ated through MAHB in J558L B cells are not stronger than
those observed for the conventional resting BCR (Fig. 2 B,
and see Fig. 7 A to follow). In addition, preliminary data
comparing the intracellular calcium levels between MAHB
versus BCR expressing J558L cells indicates that individual
cells from both lines contain baseline levels of calcium far
below levels of an aggregated BCR (unpublished data).
Additionally, if high MAHB levels were mimicking an ac-
tivated BCR, then immature B cells would undergo nega-
tive selection via apoptosis and would not be present in the
periphery. Any B cells that could survive this negative se-
lection and develop into mature B cells would express acti-
vation markers typical for a BCR cross-linked B cell, such
Figure 4. Peripheral B cell development after
adoptive transfer of MAHB-expressing  MT pro-
genitors. Splenocytes were obtained from lethally
irradiated   MT mice that had been adoptively
transferred with  MT hematopoietic progenitors
infected with MAHB or the empty virus vector
MIGR. All panels depict flow cytometric analysis
of surface B220 on splenocytes gated with forward
and side scatter to eliminate dead cells. (A) MHC
class II expression on splenocytes from MAHB
(top) or MIGR (bottom) expressing  MT mice.
Retrovirus-expressing cells were selected by gating
on GFP (right panels), whereas uninfected GFPneg
cells represented an internal negative control (left
panels). Only GFPpos cells from MAHB  MT mice
contain B cells that express MHC class II (boxed
region of top right panel). (B) Same as in panel A
except analyzed for CD23 expression. The MHC
class II positive B cells from panel A coexpress the
CD23 marker shown in B (unpublished data).1591 Bannish et al.
as CD69, CD80, and CD86. However, a significant popu-
lation of peripheral immature/mature B cells is present in
the spleens of MAHB mice (Fig. 4), and they do not ex-
hibit upregulated expression of these activation markers
(unpublished data).
To directly test whether only high MAHB levels could
be responsible for B cell developmental progression, we
compared the levels of GFP on B cells in the MAHB
mouse. B cells in the bone marrow had lower levels of
GFP than a large population of non-B, CD43pos cells, but
were similar to levels of GFP in thymocytes (Fig. 5 A, and
unpublished data). Notably, the mean GFP level of B cells
in the bone marrow was similar to that of B cells in the
spleen, indicating that high levels of MAHB did not con-
fer a selective advantage (Fig. 5 B, and unpublished data).
Multiple gates were defined in order to isolate bone mar-
row cells with various levels of GFP, and the percentage of
B cells that had transited the pro-B → pre-B block
(CD43negCD22pos) was determined. As can be seen, even
low levels of GFP, as seen in gate 4 and 5, corresponded to
a significant fraction of B cells that were CD43negCD22pos
(34 and 54%, respectively; Fig. 5 C) compared with GFPneg
(gates 2 and 3 are 12 and 10%, respectively) and GFPhigh
(gate 8, 82%). Similar results were obtained when we ana-
lyzed the additional developmental markers MHC class II
and CD23 from splenic B cells (unpublished data). These
results suggest that signals derived from the pre-BCR
may be may be similar to the basal signals derived from
MAHB.
Basal Signaling Functions of Ig /Ig  Complexes Require
Plasma Membrane Localization. To begin to define the
minimal requirements for generating biologically relevant
ligand-independent BCR signals, we have initiated struc-
ture/function analysis of MAHB in the context of pervana-
date-dependent signal initiation and proB to preB transition.
To determine whether surface localization was a require-
ment for the generation of pervanadate-induced signals, we
generated stable J558L B cell clones expressing MAHB
with amino acid substitutions at the myristoylation and
palmitoylation sites in the targeting motifs (MPP). These
mutations eliminate the fatty acid modifications that allow
targeting to the plasma membrane. MPP rather than AHB
was used as the model for surface dependence because for
reasons that remain unknown, AHB protein was degraded
more rapidly in the J558L B cell lines and could not be de-
tected. However, like AHB, MPP expression was found to
be undetectable at the cell surface by immunofluorescence
and found entirely localized to the cytoplasm (unpublished
data). We observed that signaling by the conventional
BCR and MAHB was nearly identical in the presence of
pervanadate (Fig. 6 A). The band at  21 kD in the
MAHB-expressing cells but absent in the BCR-expressing
cells represents the MAHB protein. Interestingly, signals
from the cytoplasmic MPP protein were indistinguishable
from J558L or the empty retrovirus clone MIGR 12B3, in-
dicating that surface expression of Ig  and Ig  is necessary
for generating these signals. Moreover, the MPP mutation
eliminated the ability of MAHB to drive developmental
progression of either RAG2 /  or  MT progenitors (un-
published data), indicating that the ability to generate basal
signals correlates with the ability to mediate positive selec-
tion (see the following section).
Fig. 6 B is a comparison of the relative levels of MAHB
protein expression for each of the infected lines depicted in
Fig. 6 A. Each are detected by Western blotting with anti-
HA antibody and shown as compared with protein levels of
the Fgr tyrosine kinase, also detected by Western blotting;
in this case with anti-Fgr antibodies. As expected, no
MAHB is observed in the parental J558L or J558L- m3 or
in the empty virus infected cells, whereas detectable signal
is observed in the MAHB and MPP lanes.
Figure 5. Expression level dependence of MAHB driven B cell devel-
opment from  MT progenitors. Erythrocyte-depleted cells from the bone
marrow of an MAHB reconstituted  MT mouse were analyzed for ex-
pression of B220, CD22, and CD43. (A) Live cells were selected using a
forward and side scatter gate, and analyzed for levels of GFP expression.
The reconstituted MAHB is lightly shaded, and bone marrow from a nor-
mal mouse was used as a negative control (dark shaded). (B) B cells from
the bone marrow were selected by gating on B220 and analyzed for GFP
expression. A series of gates were drawn to distinguish GFP negative (gates
2 and 3), low (gates 4 and 5), and high (gates 6–10). (C) Cells were gated
for B220 and the levels of GFP expression in B, and CD43 versus CD22
plots were obtained. For each gate, the percentage of CD22pos CD43neg
cells is shown, which represents B cell progression past the pro-B stage.1592 BCR Ligand-independent Signals for B Cell Development
Aggregation-independent Signaling and Positive Selection are
Both ITAM Dependent. Ligand-induced BCR signaling
depends upon the tyrosine residues associated with the
ITAMs of Ig  and Ig  (48, 59). To assess whether aggrega-
tion-independent signaling also required the Ig /Ig 
ITAMs, we generated J558L cell lines expressing MAHB
with Y→F substitutions in Y182, 193 and Y195, 206 of Ig  and
Ig , respectively. These mutations functionally destroy the
ability of Ig /Ig  ITAMs to transduce aggregation-depen-
dent signals (60). A panel of clones expressing either the
wild-type MAHB or the ITAM mutant was generated. For
the studies reported here, we selected four clones of each
that were matched for GFP and B220 expression levels. As
illustrated in Fig. 7 A, each of the 4 MAHB expressing
J558L B cells generated signals that were detectable in the
presence of pervanadate. In contrast, the four ITAM mu-
tant expressing cell lines (mITAM) failed to signal in the
presence of pervanadate. Clone 3–12 contained levels of
phosphotyrosine proteins that were higher than the nega-
tive controls J558L and MIGR 12B3, but were lower than
all four of the MAHB clones. Therefore, like conventional
ligand-dependent BCR signaling, basal or ligand-indepen-
dent signaling is also ITAM dependent.
Also shown in Fig. 7 are the functional effects of mutat-
ing the Ig /Ig  ITAMs associated with MAHB. Correlat-
ing with the ablation of the signaling in the J558L B cells,
the ITAM mutated MAHB (mITAM) was unable to gen-
erate signals sufficient to drive pro-B → pre-B transition
by  MT progenitors (Fig. 7 B). These studies not only
confirm previous reports for ITAM dependence for pre-
BCR–mediated positive selection, they extend these
reports by establishing the role of the ITAMs under condi-
tions where ligand-dependent signaling is eliminated. Fur-
thermore, the pervanadate studies in Fig. 7 A extend those
reported for conventional BCR signaling in the J558L sys-
tem (38) by the ITAM-dependence for basal signaling un-
der these conditions.
Discussion
We have designed a model system that allows us to iso-
late ligand-independent functions of the BCR and its de-
velopmental-associated intermediates from those functions
that are dependent on ligand-induced aggregation. By do-
ing so, we are able to focus on basal signals that are gener-
ated through these receptor complexes and to analyze their
regulation and biological relevance to B cell physiology. In
this report, we have studied the ability of basal signals to
mediate positive selection at the pro-B → pre-B check-
point. In establishing that signals modeled by MAHB are
able to mediate positive selection of B cell progenitors that
lack the ability to express pre-BCR or BCR complexes at
their plasma membrane, we extend and integrate previous
studies to evaluate ligand binding requirements for the
pre-BCR and biochemical studies of putative basal signal-
ing functions of the mature BCR. We believe that our
studies represent the first demonstration for biologically
relevant signaling through Ig /Ig  containing complexes
in which the ability to interact with extracellular ligand has
been definitively eliminated.
The implications for these studies with respect to basal
signals for survival of developing and peripheral T and B
lymphocytes is clear. In both cases, the activity of their re-
spective antigen receptors is determined by the balance of
transiently and constitutively active positive and negative
regulators such as CD45, Src family protein tyrosine kinases
(SPTK), CD22, CD5, and SHP-family protein tyrosine
phosphatases, among others (61). The transient signals that
are generated as a consequence of balancing the constitu-
tive activity of CD45 and its ability to activate receptor-
associated SPTK (62) with the inducible phosphorylation
of ITIM-containing negative regulators such as CD22 and
its ability to recruit SHP-1 to the receptor complex (61) are
postulated to constitute the basal signals that mediate the
biological effects reported in these studies. Of more general
relevance is the possibility that other receptors that initiate
Figure 6. Plasma membrane localization is required for basal signaling in the presence of protein tyrosine
phosphatase inhibitor pervanadate. (A) J558L- M3, J558L expressing the empty MIGR retrovirus
(MIGR12B3), MAHB (MAHB19A4), or MPP (clones 1, 9, 10) were cultured for 2 min in media containing 50
 M pervanadate followed by analysis of tyrosine phosphoproteins as in Fig. 2 B. The far leftmost lane depicts
J558L cells in the absence of pervanadate treatment for comparison. (B) The blot was stripped and reprobed with
antibodies to either the HA epitope tag (HA) for verification of MAHB expression, or to the B cell expressing
protein Fgr for use as a loading control (Fgr).1593 Bannish et al.
their signals via protein tyrosine kinase activation may also
have basal signaling components for their function. In all
cases, ligand induced conformational changes or aggrega-
tion may alter the signal qualitatively, or provide a mecha-
nism to sustain the signal. Given that different cellular re-
sponses are known to be triggered at different signaling
thresholds (63), the ability to elicit appropriate cellular re-
sponses to different environmental stimuli by evoking both
ligand independent as well as ligand dependent functions
for receptors provides a mechanism for enhanced flexibility
in regulating cellular physiology.
The ability of MAHB expression to drive B cell devel-
opment from  MT progenitors to the peripheral imma-
ture/mature stage definitively demonstrates the lack of a re-
quirement for overt ligand-mediated aggregation for
transition through the pro-B → pre-B checkpoint. Identi-
cal results have been obtained using progenitors derived
from bone marrow of Rag2 /  mice (unpublished data).
We interpret these findings to indicate that a low level
“basal” signal generated through this receptor provides the
signals necessary for positive selection at the pro-B → pre-B
cell stage. We further suggest that plasma membrane lo-
calization of the Ig /Ig  cytoplasmic domains is sufficient
for generating this signal. These results imply that a primary
function of the calnexin pro-B, surrogate light chain pre-B,
and fully assembled immature/mature BCR is to bring Ig 
and Ig  to the plasma membrane. By doing so, these re-
ceptor complexes herald the successful expression of mb-1
and  B29 genes (pro-BCR), followed by the successful
completion of Ig heavy chain recombination (pre-BCR),
and finally the complete assembly and function of the ma-
ture BCR. The aggregation-independent signal generated
by this surface expression may then function to positively
select those B cells in which the ordered and sequential as-
sembly of the BCR is proceeding properly.
These findings argue against a requirement for either
conventional (i.e., CDR binding) or nonconventional
ligands for generating signals for B cell–positive selection
for all but the most terminal stages of B cell development.
The lack of a requirement for conventional ligand could be
inferred from previous studies in which the antigen recog-
nition elements of the Ig heavy chain were deleted. For ex-
ample, Shaffer and Schlissel have shown that expression of
a truncated Ig heavy chain–light chain heterodimer lacking
all CDRs and therefore, the ability to bind conventional
antigen is able to generate signals sufficient to transit
through the pro-B → pre-B cell checkpoints (28). Simi-
larly, Rosado and Freitas have shown that a human
 -heavy chain lacking its variable region sequences and
unable to pair with surrogate or conventional light chains is
nonetheless able to support B cell development through
the CD23pos stage (64). Again, these results argue against
Figure 7. ITAM dependence for aggregation-independent signaling and basal signaling. (A) Pervanadate stimulation and comparison of wild-type
MAHB (clones 9A3, 5A1, 6A5, 19A4) and MAHB with mutated ITAM motifs (mITAM clones 3–2, 3–12, 7–1, 7–13) expressing J558L B cells. The in-
dicated cell lines were stimulated with pervanadate, and Western blots were probed with antiphosphotyrosine (top), anti-Fgr (middle), and anti-HA (bot-
tom; same as Fig. 6). (B) Splenic cells from  MT mice containing MAHB or mITAM were analyzed for expression of B220 and CD22 (top), or for
B220 and CD43 (bottom; same as for Fig. 3, C and D).1594 BCR Ligand-independent Signals for B Cell Development
conventional BCR ligand interactions for generating sig-
nals for B cell positive selection through the pro-B → pre-B
cell transition. In the latter studies the CD23pos B cells
were unable to enter the long-lived pool of peripheral ma-
ture B cells suggesting that maintenance of this pool may
be dependent upon conventional antigen engagement (65).
While these studies argue against a requirement for con-
ventional CDR-dependent ligand engagement in the gen-
eration of signals required for developmental progression,
they have not addressed the possibility of ligand interac-
tions mediated via other regions of the Ig heavy chain for
transition through the pro-B → pre-B cell checkpoint.
Similarly, they have not addressed the possibility that Ig 
or Ig  through their extracellular domains are involved in
interactions with nonpolymorphic ligands. Our studies ex-
tend these previous reports by ruling out involvement of
nonconventional extracellular ligands during positive selec-
tion. In addition, they establish the concept that targeting
Ig  and Ig  proteins to the plasma membrane is by itself
sufficient to generate low level and/or transient signals.
These signals, we believe regulate the survival and/or dif-
ferentiation pathways associated with positive selection and
developmental progression.
Recently, the role of plasma membrane lipid rafts in
BCR signaling has been examined. It has been reported
that in resting B cells, very few BCRs are present in rafts as
demonstrated by fluorescence confocal imaging (66) or su-
crose gradient density fractionation (44, 67). However, an-
tigen cross-linking of BCRs markedly increases the detect-
able colocalization of the receptor complex with these
plasma membrane domains (44, 66, 67). This shift allows
for colocalization of the BCR with proximal intracellular
signaling components such as doubly acylated Src family
tyrosine kinases (44, 68, 69), and possibly the exclusion of
inhibitory coreceptors such as CD45 and CD22 (70). Al-
though the published data for the BCR suggests raft local-
ization only after receptor aggregation, it remains undeter-
mined whether the BCR exists in small rafts such as those
present for other raft-associated receptors (71). These small
(26 nm) entities are undetectable by fluorescence micros-
copy and are not buoyant in sucrose density gradients.
BCR aggregation, like these other systems, would function
to coalesce “micro-rafts” and the aggregated structure
could be envisioned to function mainly to facilitate exclu-
sion of negative regulators of BCR signal transduction. Im-
portant in this regard, we find that MAHB and the
conventional BCR localize to both raft and nonraft com-
partments in resting B cells as determined by sucrose den-
sity gradients. Therefore, we do not believe that MAHB is
inappropriately targeted to regions of the membrane not
normally occupied by the conventional BCR in its nonag-
gregated state. It remains an issue for further study as to
whether basal signaling occurs for Iga/Ig  complexes when
they are localized outside of rafts, or alternatively, is medi-
ated by complexes transiently associated with these struc-
tures as has been postulated for the pre-BCR (72).
The finding that B cell development proceeds to the
classIIposCD23pos stage under the direction of MAHB raises
interesting possibilities. If these peripheral B cells have
reached the mature stage one could argue that B cell devel-
opment is regulated solely by antigen-independent mecha-
nisms. However, while these MAHB-expressing B cells
have the phenotype of more mature B cells, we have not
yet determined whether they exhibit the homing and sur-
vival characteristics of long-lived peripheral mature B cells.
Recent studies have indicated decreased survival of mature
peripheral B cells that are induced to lose surface expression
of the BCR (32) reflecting a role for either BCR surface
expression or antigen interactions for the maintenance of
this pool. The decreased survival of peripheral B cells with
surface BCR that lack the ability to bind antigen (64), as
well as the finding that peripheral naive T cells may require
interaction with some form of ligand for their continued
survival (73), suggests that development and maintenance
may depend upon different signals. While our studies argue
that developmental progression is ligand independent, it re-
mains to be determined whether MAHB-directed targeting
of Ig /Ig  is sufficient for maintenance of these peripheral
B cells. In future studies it will be interesting to test the rel-
ative lifespan of the CD23pos MAHB-expressing cells as
well as to determine their ability to compete with normal
BCR-expressing cells for follicular entry and survival.
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